Yelena Mumblat

Title: Yelena Mumblat: Innovator in Eye Disease Treatment

Introduction

Yelena Mumblat is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of medical science, particularly in the treatment of eye diseases. With a focus on innovative solutions, her work has garnered attention in both academic and medical communities.

Latest Patents

Yelena Mumblat holds 2 patents related to Semaphorin 3C variants and their applications in treating eye diseases. Her latest patents include methods for treating age-related macular degeneration (AMD) by administering Semaphorin 3C or its variants. These variants have amino acid modifications at furin-like pro-protein convertase cleavage sites, making them resistant to cleavage. Additionally, her inventions provide compositions comprising these Sema3C variants, which can be used to suppress tumor growth and inhibit the development of tumor metastases.

Career Highlights

Throughout her career, Yelena has worked with esteemed institutions such as the Rappaport Family Institute for Research in the Medical Sciences and the Technion Research & Development Foundation Limited. Her research has focused on developing innovative treatments that address critical health issues.

Collaborations

Yelena has collaborated with notable colleagues, including Gera Neufeld and Ofra Kessler. These partnerships have contributed to her success in advancing medical research and developing effective treatment methods.

Conclusion

Yelena Mumblat's work exemplifies the impact of innovation in the medical field, particularly in the treatment of eye diseases. Her patents and collaborations highlight her commitment to improving patient outcomes through scientific advancements.